Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases

International Primary Sclerosing Cholangitis Study Group (IPSCSG)

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)
125 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences